Roka Bioscience to Present at the 2017 MARCUM MICROCAP CONFERENCE

WARREN, N.J., June 9, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens,  today announced that Mary Duseau, CEO will present at the 2017 MARCUM MICROCAP CONFERENCE on June 16, 2017 at 10:30am ET. The conference will be held at The Grand Hyatt New York.

During this presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of the presentation during the event, please visit: http://rokabio.investorroom.com/. A replay of the webcast will be available for 10 days after the presentation.

The Marcum MicroCap Conference (www.marcummicrocap.com) is a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2000 investors and other participants from every segment of the microcap marketplace attend each year, including venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, and buy- and sell-side analysts, as well as senior executive teams from presenting companies and service providers to the microcap marketplace.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies.  For more information, visit http://rokabio.com.

Investor Contact: 
Roka Bioscience, Inc. 
[e-mail]
855-ROKABIO (855-765-2246)

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-2017-marcum-microcap-conference-300471806.html

SOURCE Roka Bioscience, Inc.

Copyright 2017 PR Newswire